Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 18;9(8):278.
doi: 10.3390/jcdd9080278.

Very High-Power Short-Duration (HPSD) Ablation for Pulmonary Vein Isolation: Short and Long-Term Outcome Data

Affiliations

Very High-Power Short-Duration (HPSD) Ablation for Pulmonary Vein Isolation: Short and Long-Term Outcome Data

Sebastian Seidl et al. J Cardiovasc Dev Dis. .

Abstract

Background: Circumferential pulmonary vein isolation (PVI) using radiofrequency ablation (RFA) is a standard of care intervention for patients with symptomatic atrial fibrillation (AF). During follow-up, a substantial number of patients need a redo procedure due to reconnections on the basis of insufficient non-transmural ablation lesions. High-power short-duration ablation (HPSD) is expected to create efficient lesions while causing fewer complications than in conventional RFA settings. The aim of this study was to compare one-year outcome data of very HPSD (90 Watt, 4 s) to a strategy using 50 Watt HPSD ablation guided by the CLOSE protocol using the Ablation Index (AI), an arbitrary unit composed of power, contact force and ablation time.

Methods: We retrospectively analyzed short and long-term (median follow-up 23.2 ± 9.9 months) outcome data from 52 patients that were scheduled for first-do-symptomatic PVI. A very HPSD ablation protocol with 90 Watt and a 4 s duration cut-off was compared to an HPSD CLOSE approach (50 Watts; AI 550 at the anterior LA wall; AI 400 at the posterior LA wall, the roof and the floor) in terms of freedom from AF recurrence in a long-term electrocardiogram (ECG) over a five days surveillance period. To gain an impression of the subjective sense of wellbeing, the Atrial Fibrillation Effects on QualiTy-of-Life (AFEQT) score was recorded.

Results: Overall freedom from AF was found in 81% (90 W 4 s) vs. 87.5% (50 W), (p = 0.52). There were 3 AF recurrences during the blanking period (90 W 4 s) vs. 1 (50 W). Within each population, one patient was scheduled for a redo-PVI-procedure. The AFEQT score was in favor of the 90 Watt 4 s approach (86.1 vs. 77.5; p = 0.37).

Conclusion: Within our relatively small studied population, we found hints that in addition to shortening ablation times and radiation exposure without significantly increasing the rate of relevant intraprocedural complications, very high power short-duration ablation (90 W 4 s) provides comparable efficacy rates after one year.

Keywords: atrial fibrillation; duration ablation; high power short; prognosis; pulmonary vein isolation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Patient characteristics at baseline.
Figure 2
Figure 2
Procedural data.
Figure 3
Figure 3
Comparison of procedural times between both ablation protocols.
Figure 4
Figure 4
Long-term follow-up data.
Figure 5
Figure 5
Detailed flow-chart overview of study population.
Figure 6
Figure 6
Kaplan Meier Curve outcome analysis- days from intervention to first Afib recurrence.

References

    1. Gallagher C., Hendriks J.M., Giles L., Karnon J., Pham C., Elliott A.D., Wong C.X. Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013. Heart. 2019;105:1358–1363. doi: 10.1136/heartjnl-2018-314471. - DOI - PubMed
    1. Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomström-Lundqvist C., Watkins C.L. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed with the European Association of Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 2020;42:373–498. doi: 10.1093/eurheartj/ehaa612. - DOI - PubMed
    1. Calkins H., Hindricks G., Cappato R., Kim Y.H., Saad E.B., Aguinaga L., Willems S. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. EP Eur. 2018;20:157–208. doi: 10.1093/europace/eux275. - DOI - PMC - PubMed
    1. Leshem E., Zilberman I., Tschabrunn C.M., Barkagan M., Contreras-Valdes F.M., Govari A., Anter E. High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization. JACC Clin. Electrophysiol. 2018;4:467–479. doi: 10.1016/j.jacep.2017.11.018. - DOI - PubMed
    1. Barkagan M., Contreras-Valdes F.M., Leshem E., Buxton A.E., Nakagawa H., Anter E. High power and short-duration ablation for pulmonary vein isolation: Safety, efficacy, and long-term durability. J. Cardiovasc. Electrophysiol. 2018;29:1287–1296. doi: 10.1111/jce.13651. - DOI - PubMed

LinkOut - more resources